CROSSJECT SA

ALCJ
Delayed Quote. Delayed  - 07/03 11:35:22 am
3.14EUR +5.02%
Prev.2.9900
Open2.9550
High3.2700
Low2.9050
Volume864 404
Latest news
05/22
03/29
03/28
02/18
Chart CROSSJECT SA
Technical analysis trends
Short TermMid-TermLong Term
TrendHaussireBullishBullish
Resistance3,183,744,52
Ecart / Rs.-1,3%-16%-31%
Spread/Supp.52%52%74%
Support2,062,061,80
Financials
Sales 2020 - - -
Net income 2020 - - -
Net Debt 2020 19,7 M 22,2 M 22,2 M
P/E ratio 2020 -5,41x
Yield 2020 -
Capitalization 79,6 M 89,5 M 89,6 M
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees 79
Free-Float 94,8%
Company
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Sector :
Drug Delivery Systems
Calendar :
No events available

Income Statement Evolution
Consensus
Mean consensus UNDERPERFORM
Number of Analysts 1
Average target price 1,20 €
Last Close Price 3,14 €
Spread / Highest target -61,8%
Spread / Average Target -61,8%
Spread / Lowest Target -61,8%